Empowering The Future, Decisive Growth Through GenAI And Global Acquisitions

Key Takeaways

• Accenture's record bookings and significant deals suggest solid future revenue growth from large-scale transformations and strategic reinvention partnerships.
  
• Aggressive investments in GenAI and acquisitions are expected to bolster Accenture's technology innovation forefront, market share, and long-term earnings potential.
  
• Accenture faces challenges from pricing pressures, acquisition risks, costly new technology investments, reliance on slow-revenue large deals, and a strategic but margin-impacting shift towards managed services.

Catalysts

A professional services company, provides strategy and consulting, industry X, song, and technology and operation services worldwide.

• With a focus on large-scale transformations and a strategy to be the reinvention partner for clients, Accenture's record bookings of $21.1 billion, including a significant number of large deals, suggest an expectation of revenue growth and a solid foundation for stronger future growth as these projects ramp up, impacting future revenue positively.
  
• Accenture's strategic investments in GenAI, evidenced by over $2 billion in GenAI sales year-to-date and a significant increase in GenAI-related revenue, positions the company at the forefront of a key area of technology innovation, expected to drive future revenue growth and new service opportunities, boosting both revenue and net margins.
  
• The company's aggressive capital deployment in acquisitions ($5.2 billion year-to-date) across strategic growth areas, industries, and geographies, is expected to accelerate market share expansion and scale in high-growth segments, enhancing long-term revenue and earnings potential.
  
• Continued investment in employee training and development, particularly around GenAI, alongside growth in the data and AI-skilled workforce, is positioning Accenture to lead in high-demand services areas, likely enhancing its competitive edge and contributing to future margin expansion through high-value service offerings.
  
• Accenture's strategic positioning and investments in public service and health sectors through acquisitions, seen as growth areas, indicate a strong growth outlook in these segments, potentially leading to further revenue diversification and enhanced stability in future earnings.

Assumptions

• Analysts are assuming Accenture's revenue will grow by 7.2% annually over the next 3 years.
• Analysts assume that profit margins will increase from 11.2% today to 12.1% in 3 years time.
• Analysts expect earnings to reach $9.7 billion (and earnings per share of $15.72) by about November 2027, up from $7.3 billion today. The analysts are largely in agreement about this estimate.
• In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 30.6x on those 2027 earnings, up from 30.4x today. This future PE is lower than the current PE for the US IT industry at 44.8x.
• Analysts expect the number of shares outstanding to decline by 0.41% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 8.15%, as per the Simply Wall St company report.

Risks

• Ongoing pricing pressure across all businesses, including BPO, implying a likely impact on revenue and margins.
  
• The high level of acquisitions may introduce integration risks, affecting operational efficiency and profitability.
  
• Investments in new technologies like GenAI, while critical for future growth, could initially pressure margins due to the significant up-front costs associated with training and development.
  
• Reliance on large-scale transformation deals, which convert to revenue more slowly, could lead to fluctuations in short-term revenue growth.
  
• The shift in revenue mix toward managed services, although strategic, may affect overall margin profiles if pricing pressures in BPO and similar services persist.

Valuation

• The analysts have a consensus price target of $380.21 for Accenture based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $450.0, and the most bearish reporting a price target of just $307.0.
• In order for you to agree with the analyst's consensus, you'd need to believe that by 2027, revenues will be $79.9 billion, earnings will come to $9.7 billion, and it would be trading on a PE ratio of 30.6x, assuming you use a discount rate of 8.1%.
• Given the current share price of $353.95, the analyst's price target of $380.21 is 6.9% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.